NCT00995930 Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients Status COMPLETED Phase PHASE2
NCT00994253 Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics Status WITHDRAWN Phase PHASE4
NCT00994110 Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess Status COMPLETED Phase PHASE3
NCT00991146 Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase Status COMPLETED Phase PHASE3
NCT00987545 Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence Status TERMINATED Phase PHASE2
NCT00985946 Study of Panobinostat in Patients With Neuroendocrine Tumors Status TERMINATED Phase PHASE2
NCT00983060 Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients Status COMPLETED Phase PHASE2
NCT00982033 Effects of Aliskiren on Patient With Heart Failure and a Normal Ejection Fraction Status COMPLETED Phase PHASE4
NCT00981370 Clinical Importance of Treating Iron Overload in Sickle Cell Disease Status TERMINATED Phase PHASE3
NCT00980018 An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment Status COMPLETED Phase PHASE4
NCT00975715 Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures Status COMPLETED Phase PHASE2/PHASE3
NCT00968968 Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone Status TERMINATED Phase PHASE3
NCT00968591 Pharmacokinetics of Everolimus in Subjects With Hepatic Insufficiency Status COMPLETED Phase PHASE1
NCT00967928 Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer Status WITHDRAWN Phase PHASE1
NCT00966992 Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer Status TERMINATED Phase PHASE2